Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species

Clinical Microbiology Reviews

Volumn 24, Issue 2, 2011, Pages 411-445

  Gomes, Marisa Z R ^a,b   Lewis, Russell E ^a,c   Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF HOUSTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; AMOROLFINE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CASPOFUNGIN; CICLOPIROXOLAMINE; CORTICOSTEROID; DEFERASIROX; DEFEROXAMINE; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; FLUINDOSTATIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ISAVUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; NAFTIFINE; NYSTATIN; POSACONAZOLE; POTASSIUM IODIDE; PYRROLE DERIVATIVE; RAVUCONAZOLE; RECOMBINANT GAMMA INTERFERON; RIFAMPICIN; SIMVASTATIN; TERBINAFINE; VORICONAZOLE;

ABDOMINAL INFECTION; ACTINOMUCOR ELEGANS; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; APOPHYSOMYCES ELEGANS; ARTHRITIS; BRAIN INFECTION; CARDIOVASCULAR INFECTION; CLINICAL FEATURE; COKEROMYCES RECURVATUS; CUNNINGHAMELLA BERTHOLLETIAE; DEBRIDEMENT; DRUG POTENTIATION; GRANULOCYTE TRANSFUSION; HUMAN; KIDNEY INFECTION; LUNG INFECTION; MINIMUM INHIBITORY CONCENTRATION; MUCORALES; MUCORMYCOSIS; NEPHROTOXICITY; NONHUMAN; NOSE INFECTION; ONYCHOMYCOSIS; OSTEOMYELITIS; PATHOGENESIS; PERITONITIS; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT INFECTION; REVIEW; RHIZOMUCOR PUSILLUS; RISK FACTOR; SAKSENAEA VASIFORMIS; SOFT TISSUE INFECTION; SYNCEPHALASTRUM RACEMOSUM; TAXONOMY; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; FUNGI; HUMANS; MUCORMYCOSIS; PROGNOSIS; TREATMENT OUTCOME;

ABSIDIA; ACTINOMUCOR; APOPHYSOMYCES; APOPHYSOMYCES ELEGANS; COKEROMYCES; CUNNINGHAMELLA; CUNNINGHAMELLA BERTHOLLETIAE; MUCOR; MUCORALES; RHIZOMUCOR; RHIZOMUCOR PUSILLUS; RHIZOPUS; SAKSENAEA; SAKSENAEA VASIFORMIS; SYNCEPHALASTRUM;

EID: 79955062077     PISSN: 08938512     EISSN: 10986618     Source Type: Journal    
DOI: 10.1128/CMR.00056-10     Document Type: Review

References (374)

1. Aarset, H., K. Aasarod, U. Bergan, and A. Angelsen. 2001. Acute renal infarction in a woman with slight asthma. Nephrol. Dial. Transplant. 16: 1711-1712.
2. Abdel-Hafez, S. I., A. H. Moubasher, A. A. Shoreit, and M. A. Ismail. 1990. Fungal flora associated with combine harvester wheat and sorghum dusts from Egypt. J. Basic Microbiol. 30:467-479.
3. Abuali, M. M., et al. 2009. Rhizomucor variabilis var. regularior and Hor-mographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J. Clin. Microbiol. 47:4176-4179.
4. Ajello, L., D. F. Dean, and R. S. Irwin. 1976. The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis. Mycologia 68:52-62.
5. Al-Ajam, M. R., A. R. Bizri, J. Mokhbat, J. Weedon, and L. Lutwick. 2006. Mucormycosis in the Eastern Mediterranean: a seasonal disease. Epidemiol. Infect. 134:341-346.
6. Alastruey-Izquierdo, A., et al. 2009. Activity of posaconazole and other antifungal agents against Mucorales strains identified by sequencing of internal transcribed spacers. Antimicrob. Agents Chemother. 53:1686-1689.
7. Alastruey-Izquierdo, A., et al. 2010. Species recognition and clinical relevance of the zygomycetous genus Lichtheimia (syn. Absidia pro parte, Lich-theimia). J. Clin. Microbiol. 48:2154-2170.
8. Alexander, B. D., et al. 2010. Fatal Apophysomyces elegans infection transmitted by deceased donor renal allografts. Am. J. Transplant. 10:2161-2167.
9. Al-Hedaithy, M. 1998. Cutaneous zygomycosis due to Saksenaea vasiformis: case report and literature review. Ann. Saudi Med. 18:428-431.
10. Al-Humiany, A. A. 2010. Opportunistic pathogenic fungi of the house dust in Turubah, Kingdom of Saudi Arabia. Aust. J. Basic Appl. Sci. 4:122-126.
11. Almyroudis, N. G., D. A. Sutton, A. W. Fothergill, M. G. Rinaldi, and S. Kusne. 2007. In vitro susceptibilities of 217 clinical isolates of Zygomycetes to conventional and new antifungal agents. Antimicrob. Agents Chemother. 51:2587-2590.
12. Alvarez, E., et al. 2010. Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species. Rev. Iberoam. Micol. 27:80-89.
13. Alvarez, E., et al. 2009. Spectrum of Zygomycetes species identified in clinically significant specimens in the United States. J. Clin. Microbiol. 47:1650-1656.
14. Alvarez, E., et al. 2010. Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J. Clin. Microbiol. 48:4410-4416.
15. Alvarez, O. A., J. A. Maples, F. O. Tio, and M. Lee. 1995. Severe diarrhea due to Cokeromyces recurvatus in a bone marrow transplant recipient. Am. J. Gastroenterol. 90:1350-1351.
16. Ameen, M., R. Arenas, E. Martinez-Luna, M. Reyes, and R. Zacarias. 2007. The emergence of mucormycosis as an important opportunistic fungal infection: five cases presenting to a tertiary referral center for mycology. Int. J. Dermatol. 46:380-384.
17. Amend, A. S., K. A. Seifert, R. Samson, and T. D. Bruns. 2010. Indoor fungal composition is geographically patterned and more diverse in temperate zones than in the tropics. Proc. Natl. Acad. Sci. U. S. A. 107:13748-13753.
18. Anaissie, E., et al. 1989. New spectrum of fungal infections in patients with cancer. Rev. Infect. Dis. 11:369-378.
19. Andresen, D., et al. 2005. Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet 365:876-878.
20. Antachopoulos, C., J. P. Demchok, E. Roilides, and T. J. Walsh. 2010. Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi. Mycoses 53:321-328.
21. Antoniadou, A. 2009. Outbreaks of zygomycosis in hospitals. Clin. Microbiol. Infect. 15(Suppl.):55-59.
22. Arnaiz-García, M. E., et al. 2009. Cutaneous mucormycosis: report of five cases and review of the literature. J. Plast. Reconstr. Aesthet. Surg. 62: e434-e441.
23. Axelrod, P., K. J. Kwon-Chung, P. Frawley, and H. Rubin. 1987. Chronic cystitis due to Cokeromyces recurvatus: a case report. J. Infect. Dis. 155: 1062-1064.
24. Bagy, M. M., and A. Y. Abdel-Mallek. 1991. Thermophilic and thermotol-erant fungi of animals' hair. Acta Microbiol. Hung. 38:117-120.
25. Balajee, S. A., et al. 2009. Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J. Clin. Microbiol. 47:877-884.
26. Baradkar, V. P., and S. Kumar. 2009. Cutaneous zygomycosis due to Sak-senaea vasiformis in an immunocompetent host. Indian J. Dermatol. 54: 382-384.
27. Baradkar, V. P., M. Mathur, S. Taklikar, M. Rathi, and S. Kumar. 2008. Fatal rhino-orbito-cerebral infection caused by Saksenaea vasiformis in an immunocompetent individual: first case report from India. Indian J. Med. Microbiol. 26:385-387.
28. Barbeau, D. N., L. F. Grimsley, L. E. White, J. M. El-Dahr, and M. Lichtveld. 2010. Mold exposure and health effects following hurricanes Katrina and Rita. Annu. Rev. Public Health 31:165-178.
29. Bearer, E. A., P. R. Nelson, M. Y. Chowers, and C. E. Davis. 1994. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J. Clin. Microbiol. 32:1823-1824.
30. Ben-Ami, R., M. Luna, R. E. Lewis, T. J. Walsh, and D. P. Kontoyiannis. 2009. A clinicopathological study of pulmonary mucormycosis in cancer patients: extensive angioinvasion but limited inflammatory response. J. Infect. 59:134-138.
31. Benjamin, C. R., and C. W. Hesseltine. 1957. The genus Actinomucor. Mycologia 49:240-249.
32. Bethge, W. A., et al. 2005. Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica 90(Suppl.): ECR22.
33. Bialek, R., et al. 2005. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J. Clin. Pathol. 58:1180-1184.
34. Bibashi, E., V. Sidi, M. Kotsiou, E. Makrigiannaki, and D. Koliouskas. 2008. Pulmonary zygomycosis caused by Cunninghamella bertholletiae in a child with acute lymphoblastic leukemia. Hippokratia 12:43-45.
35. Bjorkholm, M., et al. 2001. Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia. Scand. J. Infect. Dis. 33:316-319.
36. Blair, J. E., L. J. Fredrikson, B. A. Pockaj, and C. S. Lucaire. 2002. Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test. Mayo Clin. Proc. 77:717-720.
37. Blanchet, D., et al. 2008. Saksenaea vasiformis infection, French Guiana. Emerg. Infect. Dis. 14:342-344.
38. Bodhe, P. V., R. N. Kotwani, B. G. Kirodian, N. A. Kshirsagar, and S. K. Pandya. 2002. Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphoter-icin B in patients with systemic fungal infection. J. Assoc. Physicians India 50:662-670.
39. Bonito, G., O. S. Isikhuemhen, and R. Vilgalys. 2010. Identification of fungi associated with municipal compost using DNA-based techniques. Biore-sour. Technol. 101:1021-1027.
40. Boyce, J. M., L. A. Lawson, W. R. Lockwood, and J. L. Hughes. 1981. Cunninghamella bertholletiae wound infection of probable nosocomial origin. South. Med. J. 74:1132-1135.
41. Brandt, M., et al. 2006. Mold prevention strategies and possible health effects in the aftermath of hurricanes and major floods. MMWR Recomm. Rep. 55:1-27.
42. Brennan, R. O., B. J. Crain, A. M. Proctor, and D. T. Durack. 1983. Cunninghamella: a newly recognized cause of rhinocerebral mucormycosis. Am. J. Clin. Pathol. 80:98-102.
43. Brown, S. R., I. A. Shah, and M. Grinstead. 1998. Rhinocerebral mucor-mycosis caused by Apophysomyces elegans. Am. J. Rhinol. 12:289-292.
44. Burrell, S. R., D. J. Ostlie, M. Saubolle, M. Dimler, and S. D. Barbour. 1998. Apophysomyces elegans infection associated with cactus spine injury in an immunocompetent pediatric patient. Pediatr. Infect. Dis. J. 17:663-664.
45. Busca, A., et al. 2010. Combined antifungal therapy, iron chelation and surgical resection as treatment of hepatic zygomycosis in a patient with haematological malignancy. Mycoses 53:275-278.
46. Buzina, W., et al. 2003. Fungal biodiversity-as found in nasal mucus. Med. Mycol. 41:149-161.
47. Caceres, A. M., et al. 1997. Apophysomyces elegans limb infection with a favorable outcome: case report and review. Clin. Infect. Dis. 25:331-332.
48. Campelo, C., S. Miguel, and A. del Palacio. 2005. Zigomicosis rinocerebral causada por Saksenaea vasiformis en un paciente diabetico. Enferm. Infecc. Microbiol. Clin. 23:77.
49. Carter, J. E., and O. Ulusarac. 2003. Widespread cutaneous involvement by invasive Apophysomyces elegans in a gravid patient following trauma. Cutis 72:221-224, 227-228.
50. Cefai, C., T. S. Elliott, R. W. Nutton, A. E. Lockett, and J. Pooley. 1987. Zygomycetic gangrenous cellulitis. Lancet ii:1337-1338.
51. Chakrabarti, A. 2010. Cutaneous zygomycosis: major concerns. Indian J. Med. Res. 131:739-741.
52. Chakrabarti, A., et al. 2006. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med. Mycol. 44:335-342.
53. Chakrabarti, A., et al. 2001. Ten years' experience in zygomycosis at a tertiary care centre in India. J. Infect. 42:261-266.
54. Chakrabarti, A., et al. 2003. Apophysomyces elegans: an emerging zygomycete in India. J. Clin. Microbiol. 41:783-788.
55. Chakrabarti, A., et al. 1997. Craniofacial zygomycosis caused by Apophy-somyces elegans. Mycoses 40:419-421.
56. Chakrabarti, A., et al. 2010. Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern. J. Clin. Microbiol. 48:4580-4585.
57. Chakrabarti, A., et al. 1997. Primary cutaneous zygomycosis due to Sak-senaea vasiformis and Apophysomyces elegans. Clin. Infect.Dis. 24:580-583.
58. Chakrabarti, A., et al. 2009. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad. Med. J. 85:573-581.
59. Chamilos, G., and D. P. Kontoyiannis. 2006. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine. Curr. Opin. Infect. Dis. 19:380-385.
60. Chamilos, G., et al. 2008. Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis. Proc. Natl. Acad. Sci. U. S. A. 105:9367-9372.
61. Chamilos, G., R. E. Lewis, and D. P. Kontoyiannis. 2008. Delaying ampho-tericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin. Infect. Dis. 47:503-509.
62. Chamilos, G., et al. 2006. Invasive fungal infections in patients with hema-tologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 91:986-989.
63. Chander, J., J. Kaur, A. Attri, and H. Mohan. 2010. Primary cutaneous zygomycosis from a tertiary care centre in north-west India. Indian J. Med. Res. 131:765-770.
64. Cheng, V. C., et al. 2009. Outbreak of intestinal infection due to Rhizopus microsporus. J. Clin. Microbiol. 47:2834-2843.
65. Chetchotisakd, P., P. Boonma, M. Sookpranee, and C. Pairojkul. 1991. Rhinocerebral mucormycosis: a report of eleven cases. Southeast Asian J. Trop. Med. Public Health 22:268-273.
66. Chiba, N., and R. Miki. 1990. Zygomycosis caused by Cunninghamella bertholletiae. Rinsho Byori 38:1219-1225.
67. Clinical and Laboratory Standards Institute. 2008. Interpretive criteria for identification of bacteria and fungi by DNA target sequencing: guideline. CLSI, Wayne, PA.
68. Cohen-Abbo, A., P. M. Bozeman, and C. C. Patrick. 1993. Cunninghamella infections: review and report of two cases of Cunninghamella pneumonia in immunocompromised children. Clin. Infect. Dis. 17:173-177.
69. Cooter, R. D., I. S. Lim, D. H. Ellis, and I. O. Leitch. 1990. Burn wound zygomycosis caused by Apophysomyces elegans. J. Clin. Microbiol. 28:2151-2153.
70. Dabritz, J., M. Schneider, G. Just-Nübling, and A. H. Groll. 17 December 2009. Minireview: invasive fungal infection complicating acute Plasmodium falciparum malaria. Mycoses doi:10.1111/j.1439-0507.2009.01826.x.
71. Dannaoui, E. 2009. Molecular tools for identification of Zygomycetes and the diagnosis of zygomycosis. Clin. Microbiol. Infect. 15(Suppl. 5):66-70.
72. Dannaoui, E., J. Afeltra, J. F. Meis, and P. E. Verweij. 2002. In vitro susceptibilities of Zygomycetes to combinations of antimicrobial agents. Antimicrob. Agents Chemother. 46:2708-2711.
73. Dannaoui, E., J. W. Mouton, J. F. Meis, P. E. Verweij, and Eurofung Network. 2002. Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis. Antimicrob. Agents Chemother. 44:1953-1959.
74. Dannaoui, E., J. F. Meis, J. W. Mouton, and P. E. Verweij. 2002. In vitro susceptibilities of Zygomycota to polyenes. J. Antimicrob. Chemother. 49: 741-744.
75. Dannaoui, E., J. Meletiadis, J. W. Mouton, J. F. Meis, and P. E. Verweij. 2003. In vitro susceptibilities of Zygomycetes to conventional and new antifungals. J. Antimicrob. Chemother. 51:45-52.
76. Dannaoui, E., A. J. Rijs, and P. E. Verweij. 2003. Invasive infections due to Apophysomyces elegans. Mayo Clin. Proc. 78:252-253.
77. Dannaoui, E., et al. 2010. Molecular detection and identification of Zygo-mycetes species from paraffin-embedded tissues in a murine model of disseminated zygomycosis: a collaborative European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) evaluation. J. Clin. Microbiol. 48:2043-2046.
78. Darrisaw, L., G. Hanson, D. H. Vesole, and S. C. Kehl. 2000. Cunningha-mella infection post bone marrow transplant: case report and review of the literature. Bone Marrow Transplant. 25:1213-1216.
79. Davel, G., et al. 2001. Maxillary sinusitis caused by Actinomucor elegans. J. Clin. Microbiol. 39:740-742.
80. Dean, D. F., L. Ajello, R. S. Irwin, W. K. Woelk, and G. J. Skarulis. 1977. Cranial zygomycosis caused by Saksenaea vasiformis. Case report. J. Neu-rosurg. 46:97-103.
81. del Palacio, A., et al. 1999. Five cases of zygomycosis. Rev. Iberoam. Micol. 16:50-56.
82. del Palacio Hernanz, A., J. Fereres, S. Larregla Garraus, A. Rodriguez-Noriega, and F. Sanz Sanz. 1983. Nosocomial infection by Rhizomucor pusillus in a clinical haematology unit. J. Hosp. Infect. 4:45-49.
83. De Pauw, B., et al. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821.
84. Dermoumi, H. 1993. A rare zygomycosis due to Cunninghamella bertholletiae. Mycoses 36:293-294.
85. Devi, S. C., et al. 2008. Favorable outcome of amphotericin B treatment of zygomycotic necrotizing fasciitis caused by Apophysomyces elegans. Int. J. Dermatol. 47:407-409.
86. Dokmetas, H. S., et al. 2002. Diabetic ketoacidosis and rhino-orbital mu-cormycosis. Diabetes Res. Clin. Pract. 57:139-142.
87. Eaton, M. E., A. A. Padhye, D. A. Schwartz, and J. P. Steinberg. 1994. Osteomyelitis of the sternum caused by Apophysomyces elegans. J. Clin. Microbiol. 32:2827-2828.
88. el-Kady, I. A., and M. S. Youssef. 1993. Survey of mycoflora and mycotoxins in Egyptian soybean seeds. J. Basic Microbiol. 33:371-378.
89. Ellis, D. H., and G. W. Kaminski. 1985. Laboratory identification of Sak-senaea vasiformis: a rare cause of zygomycosis in Australia. Sabouraudia 23:137-140.
90. Ellis, J. J., and C. W. Heseltine. 1974. Two new families of Mucorales. Mycologia 66:87-95.
91. Erdos, M. S., K. Butt, and L. Weinstein. 1972. Mucormycotic endocarditis of the pulmonary valve. JAMA 222:951-953.
92. Espinel-Ingroff, A., et al. 2007. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with vori-conazole, posaconazole, itraconazole, amphotericin B, and caspofungin. J. Clin. Microbiol. 45:1811-1820.
93. Espinel-Ingroff, A., and E. Canton. 2008. Comparison of Neo-Sensitabs tablet diffusion assay with CLSI broth microdilution M38-A and disk diffusion methods for testing susceptibility of filamentous fungi with ampho-tericin B, caspofungin, itraconazole, posaconazole, and voriconazole. J. Clin. Microbiol. 46:1793-1803.
94. Espinel-Ingroff, A., E. Johnson, H. Hockey, and P. Troke. 2008. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole phase III clinical studies. J. Antimi-crob. Chemother. 61:616-620.
95. Eucker, J., O. Sezer, B. Graf, and K. Possinger. 2001. Mucormycoses. Mycoses 44:253-260.
96. Fairley, C., T. J. Sullivan, P. Bartley, T. Allworth, and R. Lewandowski. 2000. Survival after rhino-orbital-cerebral mucormycosis in an immuno-competent patient. Ophthalmology 107:555-558.
97. Ferguson, B. J., T. G. Mitchell, R. Moon, E. M. Camporesi, and J. Farmer. 1988. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucor-mycosis. Rev. Infect. Dis. 10:551-559.
98. Ferguson, T. D., et al. 2007. Posaconazole treatment for Apophysomyces elegans rhino-orbital zygomycosis following trauma for a male with well-controlled diabetes. J. Clin. Microbiol. 45:1648-1651.
99. Frater, J. L., G. S. Hall, and G. W. Procop. 2001. Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch. Pathol. Lab. Med. 125:375-378.
100. Galgoczy, L., G. Lukacs, I. Nyilasi, T. Papp, and C. Vagvolgyi. 2010. Anti-fungal activity of statins and their interaction with amphotericin B against clinically important Zygomycetes. Acta Biol. Hung. 61:356-365.
101. Garbino, J., C. Myers, J. Ambrosioni, and F. Gumy-Pause. 2010. Report of a successful treatment of pulmonary Cunninghamella bertholletiae infection with liposomal amphotericin and posaconazole in a child with GvHD and review of the literature. J. Pediatr. Hematol. Oncol. 32:85-87.
102. Garcia-Covarrubias, L., R. Bartlett, D. M. Barratt, and R. J. Wassermann. 2001. Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature. J. Trauma 50:353-357.
103. García-Martínez, J., F. Lopez-Medrano, A. Alhambra, and A. del Palacio. 2008. Rhinocerebral zygomycosis caused by Saksenaea vasiformis in a diabetic patient. Mycoses 51:549-553.
104. Garey, K. W., et al. 2001. Cunninghamella bertholletiae infection in a bone marrow transplant patient: amphotericin lung penetration, MIC determinations, and review of the literature. Pharmacotherapy 21:855-860.
105. Garner, D., and K. Machin. 2008. Investigation and management of an outbreak of mucormycosis in a paediatric oncology unit. J. Hosp. Infect. 70:53-59.
106. Gil, L. A., et al. 2007. Zigomicosis cutanea en un paciente de 10 años. Primer caso pediatrico en Venezuela. Revision de la literatura. Arch. Venez. Pueric. Pediatr. 70:22-27.
107. Gil-Lamaignere, C., et al. 2005. Effect of media composition and in vitro activity of posaconazole, caspofungin and voriconazole against Zygomyce-tes. J. Antimicrob. Chemother. 55:1016-1019.
108. Gil-Lamaignere, C., et al. 2005. Interferon-gamma and granulocyte-mac-rophage colony-stimulating factor augment the activity of polymorphonu-clear leukocytes against medically important Zygomycetes. J. Infect. Dis. 191:1180-1187.
109. Goldschmied-Reouven, A., A. Shvoron, M. Topaz, and C. Block. 1989. Saksenaea vasiformis infection in a burn wound. J. Med. Vet. Mycol. 27: 427-429.
110. Gomez-Lopez, A., M. Cuenca-Estrella, E. Mellado, and J. L. Rodríguez-Tudela. 2003. In vitro evaluation of combination of terbinafine with itra-conazole or amphotericin B against Zygomycota. Diagn. Microbiol. Infect. Dis. 45:199-202.
111. Gomez-Lopez, A., M. Cuenca-Estrella, A. Monzon, and J. L. Rodríguez-Tudela. 2001. In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. J. Antimicrob. Chemother. 48:919-921.
112. Gonis, G., and M. Starr. 1997. Fatal rhinoorbital mucormycosis caused by Saksenaea vasiformis in an immunocompromised child. Pediatr. Infect. Dis. J. 16:714-716.
113. Gonzalez, A., et al. 1996. Zygomycosis: review of 16 cases. Enferm. Infecc. Microbiol. Clin. 14:233-239.
114. Gonzalez, C., E. D. R. Couriel, and T. J. Walsh. 1997. Disseminated zygo-mycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin. Infect. Dis. 24:192-196.
115. Goyal, A., I. Tyagi, R. Syal, R. S. Marak, and J. Singh. 2007. Apophysomyces elegans causing acute otogenic cervicofacial zygomycosis involving salivary glands. Med. Mycol. 45:457-461.
116. Grinn-Gofron, A., A. Strzelczak, and T. Wolski. 2011. The relationships between air pollutants, meteorological parameters and concentration of airborne fungal spores. Environ. Pollut. 159:602-608.
117. Guarro, J., et al. 2011. Apophysomyces variabilis infections in humans. Emerg. Infect. Dis. 17:134-135. http://www.cdc.gov/eid/content/17/1/pdfs /134.pdf.
118. Guembe, M., J. Guinea, T. Pelaez, M. Torres-Narbona, and E. Bouza. 2007. Synergistic effect of posaconazole and caspofungin against clinical Zygo-mycetes. Antimicrob. Agents Chemother. 51:3457-3458.
119. Guinea, J., T. Pelaez, S. Recio, M. Torres-Narbona, and E. Bouza. 2008. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of Zygomycetes, Candida, Aspergillus, Fus-arium, and Scedosporium species. Antimicrob. Agents Chemother. 52:1396-1400.
120. Gutierrez Diaz, A., A. del Palacio Hernanz, S. Larregla, and A. Sanz Lopez. 1981. Orbital phycomycosis. Ophthalmologica 182:165-170.
121. Hameroff, S. B., J. W. Eckholdt, and R. Lindenberg. 1970. Cerebral phy-comycosis in a heroin addict. Neurology 20:261-265.
122. Hampson, F. G., E. J. Ridgway, K. Feeley, and J. T. Reilly. 2005. A fatal case of disseminated zygomycosis associated with the use of blood glucose self-monitoring equipment. J. Infect. 51:e269-e272.
123. Han, S. R., C. Y. Choi, M. Joo, and C. J. Whang. 2007. Isolated cerebral mucormycosis. J. Korean Neurosurg. Soc. 42:400-402.
124. Hashiguchi, K., et al. 1997. A case of pulmonary zygomycosis caused by Cunninghamella bertholletiae. Kansenshogaku Zasshi 71:264-268.
125. Hata, D. J., S. P. Buckwalter, B. S. Pritt, G. D. Roberts, and N. L. Wengenack. 2008. Real-time PCR method for detection of Zygomycetes. J. Clin. Microbiol. 46:2353-2358.
126. Hay, R. J. 2005. Mucormycosis: an infectious complication of traumatic injury. Lancet 365:830-831.
127. Hay, R. J., C. K. Campbell, W. M. Marshall, B. I. Rees, and J. Pincott. 1983. Disseminated zygomycosis (mucormycosis) caused by Saksenaea vasiformis. J. Infect. 7:162-165.
128. Hayden, R. T., X. Qian, G. W. Procop, G. D. Roberts, and R. V. Lloyd. 2002. In situ hybridization for the identification of filamentous fungi in tissue section. Diagn. Mol. Pathol. 11:119-126.
129. Henriksson, G., et al. 1997. Identification and retting efficiencies of fungi isolated from dew-retted flax in the United States and Europe. Appl. Environ. Microbiol. 63:3950-3956.
130. Hessian, P. A., and J. M. Smith. 1982. Antigenic characterization of some potentially pathogenic mucoraceous fungi. Sabouraudia 20:209-216.
131. Hibbett, D. S., et al. 2007. A higher-level phylogenetic classification of the Fungi. Mycol. Res. 111:509-547.
132. Hill, B. D., P. F. Black, M. Kelly, D. Muir, and W. A. McDonald. 1992. Bovine cranial zygomycosis caused by Saksenaea vasiformis. Aust. Vet. J. 69:173-174.
133. Hoffmann, K., S. Discher, and K. Voigt. 2007. Revision of the genus Absidia (Mucorales, Zygomycetes) based on physiological, phylogenetic, and morphological characters; thermotolerant Absidia spp. form a coherent group, Mycocladiaceae fam. nov. Mycol. Res. 111:1169-1183.
134. Holland, J. 1997. Emerging zygomycoses of humans: Saksenaea vasiformis and Apophysomyces elegans. Curr. Top. Med. Mycol. 8:27-34.
135. Honda, A., et al. 1998. A murine model of zygomycosis by Cunninghamella bertholletiae. Mycopathologia 144:141-146.
136. Hopkins, R. J., M. Rothman, A. Fiore, and S. E. Goldblum. 1994. Cerebral mucormycosis associated with intravenous drug use: three case reports and review. Clin. Infect. Dis. 19:1133-1137.
137. Horan, T. C., M. Andrus, and M. A. Dudeck. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332.
138. Horner, W. E., A. G. Worthan, and P. R. Morey. 2004. Air- and dustborne mycoflora in houses free of water damage and fungal growth. Appl. Environ. Microbiol. 70:6394-6400.
139. Huffnagle, K. E., P. M. Southern, L. T. Byrd, and R. M. Gander. 1992. Apophysomyces elegans as an agent of zygomycosis in a patient following trauma. J. Med. Vet. Mycol. 30:83-86.
140. Hutter, R. V. 1959. Phycomycetous infection (mucormycosis) in cancer patients: a complication of therapy. Cancer 12:330-350.
141. Ibrahim, A. S., B. Spellberg, and J. Edwards, Jr. 2008. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr. Opin. Infect. Dis. 21:620-625.
142. Institute of Medicine of the National Academy of Sciences. 2004. Damp indoor spaces and health. National Academy of Sciences, Washington, DC.
143. Iwen, P. C., A. G. Freifeld, L. Sigler, and S. R. Tarantolo. 2005. Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia. J. Clin. Microbiol. 43:5819-5821.
144. Jain, D., et al. 2006. Zygomycotic necrotizing fasciitis in immunocompetent patients: a series of 18 cases. Mod. Pathol. 19:1221-1226.
145. Jayasuriya, N. S., W. M. Tilakaratne, E. A. Amaratunga, and M. K. Eka-nayake. 2006. An unusual presentation of rhinofacial zygomycosis due to Cunninghamella sp. in an immunocompetent patient: a case report and literature review. Oral Dis. 12:67-69.
146. John, B. V., G. Chamilos, and D. P. Kontoyiannis. 2005. Hyperbaric oxygen as an adjunctive treatment for zygomycosis. Clin. Microbiol. Infect. 11:515-517.
147. Kamalam, A., and A. S. Thambiah. 1980. Cutaneous infection by Synceph-alastrum. Sabouraudia 18:19-20.
148. Kamei, K. 2001. Animal models of zygomycosis-Absidia, Rhizopus, Rhi-zomucor, and Cunninghamella. Mycopathologia 152:5-13.
149. Kasai, M., et al. 2008. Detection of a molecular biomarker for Zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosis. J. Clin. Microbiol. 46:3690-3702.
150. Kaufman, L., A. A. Padhye, and S. Parker. 1988. Rhinocerebral zygomy-cosis caused by Saksenaea vasiformis. J. Med. Vet. Mycol. 26:237-241.
151. Kemna, M. E., R. C. Neri, R. Ali, and I. F. Salkin. 1994. Cokeromyces recurvatus, a mucoraceous zygomycete rarely isolated in clinical laboratories. J. Clin. Microbiol. 32:843-845.
152. Kerr, O. A., C. Bong, C. Wallis, and M. J. Tidman. 2004. Primary cutaneous mucormycosis masquerading as pyoderma gangrenosum. Br. J. Dermatol. 150:1212-1213.
153. Khan, Z. U., et al. 2008. Actinomucor elegans var. kuwaitiensis isolated from the wound of a diabetic patient. Antonie Van Leeuwenhoek 94:343-352.
154. Kiehn, T. E., F. Edwards, D. Armstrong, P. P. Rosen, and I. Weitzman. 1979. Pneumonia caused by Cunninghamella bertholletiae complicating chronic lymphatic leukemia. J. Clin. Microbiol. 10:374-379.
155. Kim, J., J. K. Fortson, and H. E. Cook. 2001. A fatal outcome from rhinocerebral mucormycosis after dental extractions: a case report. J. Oral Maxillofac. Surg. 59:693-697.
156. Kimura, M., M. B. Smith, and M. R. McGinnis. 1999. Zygomycosis due to Apophysomyces elegans: report of 2 cases and review of the literature. Arch. Pathol. Lab. Med. 123:386-390.
157. Kimura, M., et al. 2009. Isolation and identification of Rhizomucor pusillus from pleural zygomycosis in an immunocompetent patient. Med. Mycol. 47:869-873.
158. Kindo, A. J., et al. 2007. Fatal cellulitis caused by Apophysomyces elegans. Indian J. Med. Microbiol. 25:285-287.
159. Knudtson, W. U., and C. A. Kirkbride. 1992. Fungi associated with bovine abortion in the northern plains states (U. S. A.). J. Vet. Diagn. Invest. 4:181-185.
160. Kobayashi, M., et al. 2004. Molecular polymerase chain reaction diagnosis of pulmonary mucormycosis caused by Cunninghamella bertholletiae. Re-spirology 9:397-401.
161. Kolbeck, P. C., R. G. Makhoul, R. R. Bollinger, and F. Sanfilippo. 1985. Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: case report and review of the literature. Am. J. Clin. Pathol. 83:747-753.
162. Kompoti, M., et al. 14 June 2010. Fatal cutaneous Saksenaea vasiformis infection in a critically ill trauma patient. Mycoses doi:10.1111/j.1439-0507.2010.01902.x.
163. Kondori, N., E. Svensson, and I. Mattsby-Baltzer. 14 June 2010. In vitro susceptibility of filamentous fungi to itraconazole, voriconazole and po-saconazole by Clinical and Laboratory Standards Institute reference method and E-test. Mycoses doi:10.1111/j.1439-0507.2010.01913.x.
164. Kontoyianis, D. P., et al. 1994. Infections due to Cunninghamella berthol-letiae in patients with cancer: report of three cases and review. Clin. Infect. Dis. 18:925-928.
165. Kontoyiannis, D. P., et al. 2007. Increased culture recovery of Zygomycetes under physiologic temperature conditions. Am. J. Clin. Pathol. 127:208-212.
166. Kontoyiannis, D. P., and R. E. Lewis. 2010. Agents of mucormycosis and entomophthoramycosis, p. 3257-3270. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 7th ed. Churchill Livingstone Elsevier, Philadelphia, PA.
167. Kontoyiannis, D. P., and R. E. Lewis. 2006. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect. Dis. Clin. North Am. 20:581-607.
168. Kontoyiannis, D. P., et al. 2005. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J. Infect. Dis. 191:1350-1360.
169. Kontoyiannis, D. P., V. C. Wessel, G. P. Bodey, and K. V. Rolston. 2000. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin. Infect. Dis. 30:851-856.
170. Kordy, F. N., et al. 2004. Successful treatment of a child with posttraumatic necrotizing fasciitis caused by Apophysomyces elegans: case report and review of literature. Pediatr. Infect. Dis. J. 23:877-879.
171. Koren, G., I. Polacheck, and H. Kaplan. 1986. Invasive mucormycosis in a non-immunocompromised patient. J. Infect. 12:165-167.
172. Koyama, N., M. Nagata, K. Hagiwara, and M. Kanazawa. 2008. Survival of a patient with pulmonary Cunninghamella bertholletiae infection without surgical intervention. Respirology 13:309-311.
173. Kramer, B. S., A. D. Hernandez, R. L. Reddick, and A. S. Levine. 1977. Cutaneous infarction. Manifestation of disseminated mucormycosis. Arch. Dermatol. 113:1075-1076.
174. Krishna, G., A. Sansone-Parsons, M. Martinho, B. Kantesaria, and L. Pedicone. 2007. Posaconazole plasma concentrations in juvenile patients with invasive fungal infection. Antimicrob. Agents Chemother. 51:812-818.
175. Kurakov, A. V., R. B. Lavrent'ev, T. Nechitailo, P. N. Golyshin, and D. G. Zviagintsev. 2008. Diversity of facultatively anaerobic microscopic mycelial fungi in soils. Mikrobiologiia 77:103-112.
176. Kwon-Chung, K. J., R. C. Young, and M. Orlando. 1975. Pulmonary mu-cormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. Am. J. Clin. Pathol. 64:544-548.
177. Lackner, A., et al. 2005. Fungi: a normal content of human nasal mucus. Am. J. Rhinol. 19:125-129.
178. Lakshmi, V., et al. 1993. Zygomycotic necrotizing fasciitis caused by Apophysomyces elegans. J. Clin. Microbiol. 31:1368-1369.
179. Lamaris, G. A., et al. 2009. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J. Infect. Dis. 199:1399-1406.
180. Larche, J., et al. 2005. Diagnosis of cutaneous mucormycosis due to Rhi-zopus microsporus by an innovative PCR-restriction fragment-length polymorphism method. Clin. Infect. Dis. 41:1362-1365.
181. Larone, D. H. 2002. Medically important fungi. A guide to identification,4th ed. ASM Press, Washington, DC.
182. Lass-Florl, C. 2009. Zygomycosis: conventional laboratory diagnosis. Clin. Microbiol. Infect. 15(Suppl. 5):60-65.
183. Lass-Florl, C., et al. 2008. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob. Agents Chemother. 52:3637-3641.
184. Lawrence, R. M., et al. 1986. Systemic zygomycosis caused by Apophysomyces elegans. J. Med. Vet. Mycol. 24:57-65.
185. Lechevalier, P., et al. 2008. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J. Clin. Microbiol. 46:3169-3172.
186. Lemmer, K., et al. 2002. Molecular biological identification of Cunninghamella spec. Mycoses 45(Suppl. 1):31-36.
187. LeSueur, B. W., K. Warschaw, and L. Fredrikson. 2002. Necrotizing cellu-litis caused by Apophysomyces elegans at a patch test site. Am. J. Contact Dermat. 13:140-142.
188. Lewis, R. E., et al. 2010. Comparative pharmacodynamics of amphotericin B lipid complex and liposomal amphotericin B in a murine model of pulmonary mucormycosis. Antimicrob. Agents Chemother. 54:1298-1304.
189. Lewis, R. E., et al. 18 October 2010. Activity of deferasirox in Mucorales: influence of species and exogenous iron. Antimicrob. Agents Chemother. doi:10.1128/AAC.00792-10.
190. Liang, K. P., I. M. Tleyjeh, W. R. Wilson, G. D. Roberts, and Z. Temesgen. 2006. Rhino-orbito-cerebral mucormycosis caused by Apophysomyces elegans. J. Clin. Microbiol. 44:892-898.
191. Linares, M. J., et al. 2005. Susceptibility of filamentous fungi to voricona-zole tested by two microdilution methods. J. Clin. Microbiol. 43:250-253.
192. Lionakis, M. S., and D. P. Kontoyiannis. 2003. Glucocorticoids and invasive fungal infections. Lancet 362:1828-1838.
193. Lionakis, M. S., and D. P. Kontoyiannis. 2004. The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer. Cancer 100:165-172.
194. Lombardi, G., A. A. Padhye, P. G. Standard, L. Kaufman, and L. Ajello. 1989. Exoantigen tests for the rapid and specific identification of Apophy-somyces elegans and Saksenaea vasiformis. J. Med. Vet. Mycol. 27:113-120.
195. Lozano, F., E. Martín, P. Jimenez, E. Hidalgo, and A. Robles. 1999. Necrotizing cellulitis of the hand and forearm in a hospitalized diabetic patient. Enferm. Infecc. Microbiol. Clin. 17:37-38.
196. Lu, X. L., et al. 2009. Primary cutaneous zygomycosis caused by Rhizomucor variabilis: a new endemic zygomycosis? A case report and review of 6 cases reported from China. Clin. Infect. Dis. 49:e39-e43.
197. Lucet, A., and J. Constantin. 1901. Contributions a l'etude des mucorin ́ees pathologenes. Arch. Parasitol. 4:362-408.
198. Lukacs, G., T. Papp, I. Nyilasi, E. Nagy, and C. Vagvolgyi. 2004. Differentiation of Rhizomucor species on the basis of their different sensitivities to lovastatin. J. Clin. Microbiol. 42:5400-5402.
199. Lye, G. R., G. Wood, and G. Nimmo. 1996. Subcutaneous zygomycosis due to Saksenaea vasiformis: rapid isolate identification using a modified spo-rulation technique. Pathology 28:364-365.
200. Ma, B., J. F. Seymour, H. Januszewicz, and M. A. Slavin. 2001. Cure of pulmonary Rhizomucor pusillus infection in a patient with hairy-cell leukemia: role of liposomal amphotericin B and GM-CSF. Leuk. Lymphoma 42:1393-1399.
201. Machouart, M., et al. 2006. Genetic identification of the main opportunistic Mucorales by PCR-restriction fragment length polymorphism. J. Clin. Mi-crobiol. 44:805-810.
202. Maghazy, S. M., A. Y. Abdel-Mallek, and M. M. Bagy. 1989. Fungi in two swimming pools in Assiut town, Egypt. Zentralbl. Mikrobiol. 144:213-216.
203. Maloisel, F., et al. 1991. Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review. Nouv. Rev. Fr. Hematol. 33:311-315.
204. Marak, R. S., et al. 1 April 2010. Successful medical management of renal zygomycosis: a summary of two cases and a review of the Indian literature. Med. Mycol. doi:10.3109/13693781003753477.
205. Mathews, M. S., A. Raman, and A. Nair. 1997. Nosocomial zygomycotic post-surgical necrotizing fasciitis in a healthy adult caused by Apophysomy-ces elegans in south India. J. Med. Vet. Mycol. 35:61-63.
206. Mayayo, E., C. Klock, and L. Goldani. 24 January 2009. Thyroid involvement in disseminated zygomycosis by Cunninghamella bertholletiae: 2 cases and literature review. Int. J. Surg. Pathol. doi:10.1177/1066896908329595.
207. Mazade, M. A., J. F. Margolin, S. N. Rossmann, and M. S. Edwards. 1998. Survival from pulmonary infection with Cunninghamella bertholletiae: case report and review of the literature. Pediatr. Infect. Dis. J. 17:835-839.
208. McGinnis, M. R., J. Midez, L. Pasarell, and A. Haque. 1993. Necrotizing fasciitis caused by Apophysomyces elegans. J. Mycol. Med. 3:175-179.
209. McGinnis, M. R., D. H. Walker, I. E. Dominy, and W. Kaplan. 1982. Zygomycosis caused by Cunninghamella bertholletiae: clinical and pathologic aspects. Arch. Pathol. Lab. Med. 106:282-286.
210. McGough, D. A., A. W. Fothergill, and M. G. Rinaldi. 1990. Cokeromyces recurvatus Poitras, a distinctive zygomycete and potential pathogen: criteria for identification. Clin. Microbiol. Newsl. 12:113-117.
211. Mehta, N. N., J. Romanelli, and M. G. Sutton. 2004. Native aortic valve vegetative endocarditis with Cunninghamella. Eur. J. Echocardiogr. 5:156-158.
212. Meis, J. F., B. J. Kullberg, M. Pruszczynski, and R. P. Veth. 1994. Severe osteomyelitis due to the zygomycete Apophysomyces elegans. J. Clin. Mi-crobiol. 32:3078-3081.
213. Meyer, R. D., M. H. Kaplan, M. Ong, and D. Armstrong. 1973. Cutaneous lesions in disseminated mucormycosis. JAMA 225:737-738.
214. Mirza, J. H., S. M. Khan, S. Begum, and S. Shagufta. 1979. Mucorales of Pakistan. University of Agriculture, Faisalabad, Pakistan.
215. Misra, P. C., K. J. Srivastva, and K. Lata. 1979. Apophysomyces, a new genus of the Mucorales. Mycotaxon 8:377-382.
216. Mori, T., et al. 2003. Zygomycosis: two case reports and review of reported cases in the literature in Japan. Nippon Ishinkin Gakkai Zasshi 44:163-179.
217. Mostaza, J. M., F. J. Barbado, J. Fernandez-Martin, J. Pena-Yanez, and J. J. Vazquez-Rodriguez. 1989. Cutaneoarticular mucormycosis due to Cun-ninghamella bertholletiae in a patient with AIDS. Rev. Infect. Dis. 11:316-318.
218. Motohashi, K., et al. 2009. Cutaneous zygomycosis caused by Cunninghamella bertholletiae in a patient with chronic myelogenous leukemia in blast crisis. Am. J. Hematol. 84:447-448.
219. Munipalli, B., M. G. Rinaldi, and S. B. Greenberg. 1996. Cokeromyces recurvatus isolated from pleural and peritoneal fluid: case report. J. Clin. Microbiol. 34:2601-2603.
220. Murray, P. R., and F. G. Witesbsky. 2010. The clinician and the microbiology laboratory, p. 233-266. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 7th ed. Churchill Livingstone Elsevier, Philadelphia, PA.
221. Naguib, M. T., et al. 1995. Apophysomyces elegans infection in a renal transplant recipient. Am. J. Kidney Dis. 26:381-384.
222. Naumann, R., M. L. Kerkmann, U. Schuler, W. G. Daniel, and G. Eh-ninger. 1999. Cunninghamella bertholletiae infection mimicking myocardial infarction. Clin. Infect. Dis. 29:1580-1581.
223. Newton, W. D., F. S. Cramer, and S. H. Norwood. 1987. Necrotizing fasciitis from invasive Phycomycetes. Crit. Care Med. 15:331-332.
224. Ng, T. T., et al. 1994. Successful treatment of sinusitis caused by Cunning-hamella bertholletiae. Clin. Infect. Dis. 19:313-316.
225. Nicod, J. L., C. Fleury, and J. Schlegel. 1952. Mixed micotic infection of the lungs with Aspergillus fumigatus Fres. and Mucor pusillus Lindt. Schweiz. Z. Pathol. Bakteriol. 15:307-321.
226. Nielsen, C., D. A. Sutton, I. Matise, N. Kirchhof, and M. C. Libal. 2005. Isolation of Cokeromyces recurvatus, initially misidentified as Coccidioides immitis, from peritoneal fluid in a cat with jejunal perforation. J. Vet. Diagn. Invest. 17:372-378.
227. Nimmo, G. R., R. F. Whiting, and R. W. Strong. 1988. Disseminated mu-cormycosis due to Cunninghamella bertholletiae in a liver transplant recipient. Postgrad. Med. J. 64:82-84.
228. Noble, W. C., and Y. M. Clayton. 1963. Fungi in the air of hospital wards. J. Gen. Microbiol. 32:397-402.
229. Nyilasi, I., et al. 2008. High-affinity iron permease (FTR1) gene sequence-based molecular identification of clinically important Zygomycetes. Clin. Microbiol. Infect. 14:393-397.
230. Oberle, A. D., and R. L. Penn. 1983. Nosocomial invasive Saksenaea vasifor-mis infection. Am. J. Clin. Pathol. 80:885-888.
231. Ogundero, V. W. 1979. Thermophilic and thermotolerant fungi in poultry droppings in Nigeria. J. Gen. Microbiol. 115:253-254.
232. Ogundero, V. W., and J. O. Aina. 1989. Storage temperature and viability of sporangiospores of potentially human pathogenic species of Rhizomucor from Nigerian tobacco. J. Basic Microbiol. 29:171-175.
233. Ogunlana, E. O. 1975. Fungal air spora at Ibadan, Nigeria. Appl. Microbiol. 29:458-463.
234. Okhuysen, P. C., J. H. Rex, M. Kapusta, and C. Fife. 1994. Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans. Clin. Infect. Dis. 19:329-331.
235. Ortega, J., et al. 2010. Zygomycotic lymphadenitis in slaughtered feedlot cattle. Vet. Pathol. 47:108-115.
236. Ortín, X., et al. 2004. Cunninghamella bertholletiae infection (mucormyco-sis) in a patient with acute T-cell lymphoblastic leukemia. Leuk. Lymphoma 45:617-620.
237. Ostrosky-Zeichner, L., and J. H. Rex. 2004. Filamentous fungi, p. 705-708. In C. G. Mayhall (ed.), Hospital epidemiology and infection control, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, PA.
238. Otcenasek, M., and V. Buchta. 1994. In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens. Mycopathologia 128:135-137.
239. Padhye, A. A., and L. Ajello. 1988. Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis. J. Clin. Microbiol. 26:1861-1863.
240. Padhye, A. A., et al. 1988. First case of subcutaneous zygomycosis caused by Saksenaea vasiformis in India. Diagn. Microbiol. Infect. Dis. 9:69-77.
241. Padmaja, I. J., T. V. Ramani, and S. Kalyani. 2006. Cutaneous zygomycosis: necrotising fasciitis due to Saksenaea vasiformis. Indian J. Med. Microbiol. 24:58-60.
242. Pagano, L., B. Gleissner, and L. Fianchi. 2005. Breakthrough zygomycosis and voriconazole. J. Infect. Dis. 192:1496-1497.
243. Pagano, L., et al. 2004. Mucormycosis in hematologic patients. Haematologica 89:207-214.
244. Pagano, L., C. G. Valentini, M. Caira, and L. Fianchi. 2009. Zygomycosis: current approaches to management of patients with haematological malignancies. Br. J. Haematol. 146:597-606.
245. Pagano, L., C. G. Valentini, L. Fianchi, and M. Caira. 2009. The role of neutrophils in the development and outcome of zygomycosis in haemato-logical patients. Clin. Microbiol. Infect. 15(Suppl. 5):33-36.
246. Page, R., D. J. Gardam, and C. H. Heath. 2001. Severe cutaneous mucor-mycosis (Zygomycosis) due to Apophysomyces elegans. ANZ J. Surg. 71: 184-186.
247. Panackal, A. A., et al. 2010. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin. Infect. Dis. 50:1588-1597.
248. Pandian, J. D., J. S. McCarthy, T. Goldschlager, T. Robertson, and R. D. Henderson. 2007. Rhizomycosis infection in the basal ganglia. Arch. Neurol. 64:134-135.
249. Parker, C., G. Kaminski, and D. Hill. 1986. Zygomycosis in a tattoo, caused by Saksenaea vasiformis. Australas. J. Dermatol. 27:107-111.
250. Passos, X. S., et al. 2006. Nosocomial invasive infection caused by Cunninghamella bertholletiae: case report. Mycopathologia 161:33-35.
251. Pastor, F. J., et al. 19 August 2010. In vitro and in vivo antifungal susceptibilities of the mucoralean fungus Cunninghamella. Antimicrob. Agents Chemother. doi:10.1128/AAC.00786-10.
252. Patino, J. F., R. Mora, M. A. Guzman, and E. Rodríguez-Franco. 1984. Mucormycosis: a fatal case by Saksenaea vasiformis. World J. Surg. 8:419-422.
253. Patterson, J. E., A. Zidouh, P. Miniter, V. T. Andriole, and T. F. Patterson. 1997. Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infect. Control Hosp. Epidemiol. 18:104-108.
254. Paul, S., F. M. Marty, and Y. L. Colson. 2006. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. Ann. Thorac. Surg. 82:338-340.
255. Pavlovic, M. D., and N. Bulajic. 2006. Great toenail onychomycosis caused by Syncephalastrum racemosum. Dermatol. Online J. 12:17.
256. Perkhofer, S., V. Lechner, and C. Lass-Flörl. 2009. In vitro activity of isavuconazole against Aspergillus species and Zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob. Agents Chemother. 53:1645-1647.
257. Perkhofer, S., et al. 2008. Posaconazole enhances the activity of amphoter-icin B against hyphae of Zygomycetes in vitro. Antimicrob. Agents Che-mother. 52:2636-2638.
258. Peter, E., F. Bakri, D. M. Ball, R. T. Cheney, and B. H. Segal. 2002. Invasive pulmonary filamentous fungal infection in a patient receiving inhaled cor-ticosteroid therapy. Clin. Infect. Dis. 35:e54-e56.
259. Piao, Y. S., Y. Zhang, X. Yang, C. Y. He, and H. G. Liu. 2008. The use of MUC5B antibody in identifying the fungal type of fungal sinusitis. Hum. Pathol. 39:650-656.
260. Pierce, P. F., et al. 1987. Saksenaea vasiformis osteomyelitis. J. Clin. Micro-biol. 25:933-935.
261. Pimentel, J. D., G. Dreyer, and G. D. Lum. 2006. Peritonitis due to Cunninghamella bertholletiae in a patient undergoing continuous ambulatory peritoneal dialysis. J. Med. Microbiol. 55:115-118.
262. Pongas, G. N., R. Ben-Ami, R. E. Lewis, T. J. Walsh, and D. P. Kontoyi-annis. 2009. Culture medium composition affects the lethality of Cunning-hamella bertholletiae in a fly model of mucormycosis. Antimicrob. Agents Chemother. 53:4569.
263. Pongas, G. N., R. E. Lewis, G. Samonis, and D. P. Kontoyiannis. 2009. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? Clin. Microbiol. Infect. 15(Suppl. 5):93-97.
264. Prabhu, R. M., and R. Patel. 2004. Mucormycosis and entomophthoramy-cosis: a review of the clinical manifestations, diagnosis and treatment. Clin. Microbiol. Infect. 10(Suppl. 1):31-47.
265. Pritchard, R. C., D. B. Muir, K. H. Archer, and J. M. Beith. 1986. Subcutaneous zygomycosis due to Saksenaea vasiformis in an infant. Med. J. Aust. 145:630-631.
266. Quinio, D., et al. 2004. Zygomycosis caused by Cunninghamella bertholletiae in a kidney transplant recipient. Med. Mycol. 42:177-180.
267. Radner, A. B., M. D. Witt, and J. E. Edwards, Jr. 1995. Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin. Infect. Dis. 20:163-166.
268. Rainer, J., U. Peintner, and R. Pöder. 2001. Biodiversity and concentration of airborne fungi in a hospital environment. Mycopathologia 149:87-97.
269. Ramani, R., et al. 2000. Cokeromyces recurvatus as a human pathogenic fungus: case report and critical review of the published literature. Pediatr. Infect. Dis. J. 19:155-158.
270. Ramesh, V. M., et al. 25 February 2010. Subcutaneous zygomycosis: report of 10 cases from two institutions in North India. J. Eur. Acad. Dermatol. Venereol. doi:10.1111/j.1468-3083.2010.03606.x.
271. Rao, C. Y., et al. 2007. Implications of detecting the mold Syncephalastrum in clinical specimens of New Orleans residents after Hurricanes Katrina and Rita. J. Occup. Environ. Med. 49:411-416.
272. Rao, C. Y., et al. 2007. Characterization of airborne molds, endotoxins, and glucans in homes in New Orleans after Hurricanes Katrina and Rita. Appl. Environ. Microbiol. 73:1630-1634.
273. Ravisse, P., H. Fromentin, P. Destombes, and F. Mariat. 1978. Cerebral mucormycosis in the cat caused by Mucor pusillus. Sabouraudia 16:291-298.
274. Reddy, I. S., N. R. Rao, V. M. Shankar Reddy, and R. Rao. 2008. Primary cutaneous mucormycosis (zygomycosis) caused by Apophysomyces elegans. Indian J. Dermatol. Venereol. Leprol. 74:367-370.
275. Reed, A. E., B. A. Body, M. B. Austin, and H. F. Frierson. 1988. Cunninghamella bertholletiae and Pneumocystis carinii pneumonia as a fatal complication of chronic lymphocytic leukemia. Hum. Pathol. 19:1470-1472.
276. Reinhardt, D. J., et al. 1981. Experimental cerebral zygomycosis in alloxan-diabetic rabbits: variation in virulence among Zygomycetes. Sabouraudia 19:245-256.
277. Rex, J. H., A. M. Ginsberg, L. F. Fries, H. I. Pass, and K. J. Kwon-Chung. 1988. Cunninghamella bertholletiae infection associated with deferoxamine therapy. Rev. Infect. Dis. 10:1187-1194.
278. Ribes, J. A., C. L. Vanover-Sams, and D. J. Baker. 2000. Zygomycetes in human disease. Clin. Microbiol. Rev. 13:236-301.
279. Richardson, M. 2009. The ecology of the Zygomycetes and its impact on environmental exposure. Clin. Microbiol. Infect. 15(Suppl. 5):2-9.
280. Rickerts, V., et al. 2006. Successful treatment of disseminated mucormyco-sis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia. Mycoses 49(Suppl. 1):27-30.
281. Rickerts, V., et al. 2000. Cluster of pulmonary infections caused by Cun-ninghamella bertholletiae in immunocompromised patients. Clin. Infect. Dis. 31:910-913.
282. Righi, E., et al. 2008. A case of Cunninghamella bertholletiae rhino-cerebral infection in a leukaemic patient and review of recent published studies. Mycopathologia 165:407-410.
283. Rippon, J. W., and C. T. Dolan. 1979. Colonization of the vagina by fungi of the genus Mucor. Clin. Microbiol. Newsl. 1:4-5.
284. Robeck, T. R., and L. M. Dalton. 2002. Saksenaea vasiformis and Apophy-somyces elegans zygomycotic infections in bottlenose dolphins (Tursiops truncatus), a killer whale (Orcinus orca), and Pacific white-sided dolphins (Lagenorhynchus obliquidens). J. Zoo Wildl. Med. 33:356-366.
285. Robinson, B. E., M. T. Stark, T. L. Pope, F. M. Stewart, and G. R. Donowitz. 1990. Cunninghamella bertholletiae: an unusual agent of zygomycosis. South. Med. J. 83:1088-1091.
286. Roden, M. M., et al. 2005. Epidemiology and outcome of mucormycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653.
287. Rodríguez, M. M., et al. 2010. Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice. Antimicrob. Agents Chemother. 54:1665-1669.
288. Rodriguez-Romero, J., M. Hedtke, C. Kastner, S. Muller, and R. Fischer. 2010. Fungi, hidden in soil or up in the air: light makes a difference. Annu. Rev. Microbiol. 64:585-610.
289. Rolandi, L., L. Lodola, M. Guglielminetti, G. Caretta, and G. Azzarett. 1998. Evaluation of airborne particulate and fungi in critical hospital care units. Toxicol. Lett. 95:226.
290. Ruiz, C. E., M. Arango, A. L. Correa, L. S. Lopez, and A. Restrepo. 2004. Necrotizing fasciitis in an immunocompetent patient caused by Apophyso-myces elegans. Biomedica 24:239-251.
291. Ruping, M. J., et al. 2010. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J. Antimicrob. Chemother. 65:296-302.
292. Ryan, L. J., P. Ferrieri, R. Powell, S. Zeki, and S. Pambuccian. 14 January 2009. Fatal Cokeromyces recurvatus pneumonia: report of a case highlighting the potential for histopathologic misdiagnosis as Coccidioides. Int. J. Surg. Pathol. doi:10.1177/1066896908330483.
293. Ryan, M. E., D. Ochs, and J. Ochs. 1982. Primary cutaneous mucormycosis: superficial and gangrenous infections. Pediatr. Infect. Dis. 1:110-114.
294. Saksena, S. B. 1953. A new genus of the Mucorales. Mycologia 45:426-436.
295. Sands, J. M., A. M. Macher, T. J. Ley, and A. W. Nienhuis. 1985. Disseminated infection caused by Cunninghamella bertholletiae in a patient with beta-thalassemia. Case report and review of the literature. Ann. Intern. Med. 102:59-63.
296. Saoulidis, S. M., et al. 29 October 2010. Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model. Mycoses doi:10.1111/j.1439-0507.2010.01958.x.
297. Saravia-Flores, M., D. M. Guaran, and V. Argueta. 2010. Invasive cutaneous infection caused by Apophysomyces elegans associated with a spider bite. Mycoses 53:259-261.
298. Schell, W. A., M. G. Johnson, M. R. McGinnis, I. Weitzman, and M. Y. Crist. 1982. Zygomycosis caused by Cunninghamella bertholletiae: mycologic aspects. Arch. Pathol. Lab. Med. 106:287-291.
299. Schipper, M. A. A. 1978. On the genera Rhizomucor and Parasitella. Stud. Mycol. 17:52-71.
300. Schlebusch, S., and D. F. Looke. 2005. Intra-abdominal zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high-dose amphotericin B lipid complex. J. Clin. Microbiol. 43:5825-5827.
301. Schnurer, A., and J. Schnurer. 2006. Fungal survival during anaerobic digestion of organic household waste. Waste Manag. 26:1205-1211.
302. Schostakowitsch, W. 1898. Actinomucor repens n. g. n. sp. Ber. Dtsch. Bot. Ges. 16:155-158.
303. Schutz, P., et al. 2006. Fatal rhino-orbito-cerebral zygomycosis caused by Apophysomyces elegans in a healthy patient. J. Oral Maxillofac. Surg. 64: 1795-1802.
304. Schwarz, P., et al. 2006. Molecular identification of Zygomycetes from culture and experimentally infected tissues. J. Clin. Microbiol. 44:340-349.
305. Schwarz, P., O. Lortholary, F. Dromer, and E. Dannaoui. 2007. Carbon assimilation profiles as a tool for identification of Zygomycetes. J. Clin. Microbiol. 45:1433-1439.
306. Sdralis, T., S. Krishnan, and J. Holland. 1997. "Martini glass" mucormy-cosis-Apophysomyces elegans infection in an immune competent host. Aust. J. Otolaryngol. 2:600-602.
307. Severo, L. C., F. Job, and T. C. Mattos. 1991. Systemic zygomycosis: nos-ocomial infection by Rhizomucor pusillus. Mycopathologia 113:79-80.
308. Shanor, L., A. W. Poitras, and R. K. Benjamin. 1950. A new genus of the Choanephoraceae. Mycologia 42:271-278.
309. Shelton, B. G., K. H. Kirkland, W. D. Flanders, and G. K. Morris. 2002. Profiles of airborne fungi in buildings and outdoor environments in the United States. Appl. Environ. Microbiol. 68:1743-1753.
310. Simitsopoulou, M., E. Georgiadou, T. J. Walsh, and E. Roilides. 2010. Cunninghamella bertholletiae exhibits increased resistance to human neu-trophils with or without antifungal agents as compared to Rhizopus spp. Med. Mycol. 48:720-724.
311. Singh, J., D. Rimek, and R. Kappe. 2005. In vitro susceptibility of 15 strains of Zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses 48:246-250.
312. Sivakumar, S., M. S. Mathews, and B. George. 2005. Cunninghamella pneumonia in post-bone marrow transplant patient: first case report from India. Mycoses 48:360-362.
313. Skiada, A. L., et al. 2 January 2011. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin. Microbiol. Infect. doi:10.1111/j.1469-0691.2010.03456.x.
314. Snell, B. J., and K. Tavakoli. 2007. Necrotizing fasciitis caused by Apophy-somyces elegans complicating soft-tissue and pelvic injuries in a tsunami survivor from Thailand. Plast. Reconstr. Surg. 119:448-449.
315. Solano, T., B. Atkins, E. Tambosis, S. Mann, and T. Gottlieb. 2000. Disseminated mucormycosis due to Saksenaea vasiformis in an immunocom-petent adult. Clin. Infect. Dis. 30:942-943.
316. Spellberg, B., T. J. Walsh, D. P. Kontoyiannis, J. Edwards, and A. S. Ibrahim. 2009. Recent advances in the management of mucormycosis: from bench to bedside. Clin. Infect. Dis. 48:1743-1751.
317. Sridhara, S. R., G. Paragache, N. K. Panda, and A. Chakrabarti. 2005. Mucormycosis in immunocompetent individuals: an increasing trend. J. Otolaryngol. 34:402-406.
318. Stewardson, A. J., N. E. Holmes, D. H. Ellis, and B. P. Howden. 2009. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman. Mycoses 52: 547-549.
319. Germain, G., A. Robert, M. Ishak, C. Tremblay, and S. Claveau. 1993. Infection due to Rhizomucor pusillus: report of four cases in patients with leukemia and review. Clin. Infect. Dis. 16:640-645.
320. Sun, Q. N., A. W. Fothergill, D. I. McCarthy, M. G. Rinaldi, and J. R. Graybill. 2002. In vitro activities of posaconazole, itraconazole, voricona-zole, amphotericin B, and fluconazole against 37 clinical isolates of Zygo-mycetes. Antimicrob. Agents Chemother. 46:1581-1582.
321. Suryanarayan Rao, S., N. K. Panda, G. Pragache, A. Chakrabarti, and K. Saravanan. 2006. Sinoorbital mucormycosis due to Apophysomyces elegans in immunocompetent individuals-an increasing trend. Am. J. Otolaryngol. 27:366-369.
322. Tajdini, F., M. A. Amini, N. Nafissi-Varcheh, and M. A. Faramarzi. 2010. Production, physiochemical and antimicrobial properties of fungal chitosan from Rhizomucor miehei and Mucor racemosus. Int. J. Biol. Macromol. 47:180-183.
323. Talwar, P., et al. 1988. Fungal infections of ear with special reference to chronic suppurative otitis media. Mycopathologia 104:47-50.
324. Tanabe, Y., M. Saikawa, M. M. Watanabe, and J. Sugiyama. 2004. Molecular phylogeny of Zygomycota based on EF-1alpha and RPB1 sequences: limitations and utility of alternative markers to rDNA. Mol. Phylogenet. Evol. 30:438-449.
325. Tanphaichitr, V. S., A. Chaiprasert, V. Suvatte, and P. Thasnakorn. 1990. Subcutaneous mucormycosis caused by Saksenaea vasiformis in a thalassaemic child: first case report in Thailand. Mycoses 33:303-309.
326. Thomas, A. J., S. Shah, M. S. Mathews, and N. Chacko. 2008. Apophyso-myces elegans-renal mucormycosis in a healthy host: a case report from south India. Indian J. Med. Microbiol. 26:269-271.
327. Tomita, H. E., et al. 10 November 2010. Rhizomucor variabilis infection in human cutaneous mucormycosis. Clin. Exp. Dermatol. doi:10.1111/j.1365-2230.2010.03956.x.
328. Torell, J., B. H. Cooper, and N. G. Helgeson. 1981. Disseminated Saksenaea vasiformis infection. Am. J. Clin. Pathol. 76:116-121.
329. Torres-Narbona, M., J. Guinea, J. Martínez-Alarcon, T. Pelaez, and E. Bouza. 2007. In vitro activities of amphotericin B, caspofungin, itracona-zole, posaconazole, and voriconazole against 45 clinical isolates of Zygo-mycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrob. Agents Chemother. 51:1126-1129.
330. Tortorano, A. M., et al. 2009. Molecular identification and in vitro antifun-gal susceptibilities of 28 Zygomycetes isolates: FIMUA-ECMM survey of zygomycosis in Italy. J. Chemother. 21:363-364.
331. Tragiannidis, A., and A. H. Groll. 2009. Hyperbaric oxygen therapy and other adjunctive treatments for zygomycosis. Clin. Microbiol. Infect. 15(Suppl. 5):82-86.
332. Trifilio, S., et al. 2007. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic vori-conazole. Bone Marrow Transplant. 40:451-456.
333. Trotter, D. J., G. Gonis, E. Cottrill, and C. Coombs. 2008. Disseminated Saksenaea vasiformis in an immunocompetent host. Med. J. Aust. 189:519-520.
334. Tsai, T. W., et al. 1997. Cokeromyces recurvatus infection in a bone marrow transplant recipient. Bone Marrow Transplant. 19:301-302.
335. Tully, C. C., A. M. Romanelli, D. A. Sutton, B. L. Wickes, and D. R. Hospenthal. 2009. Fatal Actinomucor elegans var. kuwaitiensis infection following combat trauma. J. Clin. Microbiol. 47:3394-3399.
336. Ullmann, A. J., et al. 2007. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N. Engl. J. Med. 356:335-347.
337. Valentini, C. G., et al. 2010. Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies. Mycoses 53:89-92.
338. van Burik, J. A., R. S. Hare, H. F. Solomon, M. L. Corrado, and D. P. Kontoyiannis. 2006. Posaconazole is effective as salvage therapy in zygo-mycosis: a retrospective summary of 91 cases. Clin. Infect. Dis. 42:e61-e65.
339. van Heerden, I., C. Cronje, S. H. Swart, and J. M. Kotze. 2002. Microbial, chemical and physical aspects of citrus waste composting. Bioresour. Technol. 81:71-76.
340. Vastag, M., et al. 2004. Cloning and sequence analysis of the glyceralde-hyde-3-phosphate dehydrogenase gene from the Zygomycetes fungus Rhi-zomucor miehei. Antonie Van Leeuwenhoek 86:111-119.
341. Vastag, M., T. Papp, Z. Kasza, and C. Vágvölgyi. 2000. Intraspecific variation in two species of Rhizomucor assessed by random amplified polymorphic DNA analysis. J. Basic Microbiol. 40:269-277.
342. Vega, W., M. Orellana, L. Zaror, J. Gene, and J. Guarro. 2006. Saksenaea vasiformis infections: case report and literature review. Mycopathologia 162:289-294.
343. Ventura, G. J., H. M. Kantarjian, E. Anaissie, R. L. Hopfer, and V. Fain-stein. 1986. Pneumonia with Cunninghamella species in patients with hematologic malignancies. A case report and review of the literature. Cancer 58:1534-1536.
344. Venugopal, P. L., T. L. Venugopal, A. Gomathi, E. S. Ramakrishna, and S. Ilavarasi. 1989. Mycotic keratitis in Madras. Indian J. Pathol. Microbiol. 32:190-197.
345. Verma, A., B. Brozman, and C. K. Petito. 2006. Isolated cerebral mucor-mycosis: report of a case and review of the literature. J. Neurol. Sci. 240:65-69.
346. Vigouroux, S., et al. 2005. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin. Infect. Dis. 40:e35-e37.
347. Viscoli, C., and E. Castagnola. 2010. Geoclimatic factors and invasive aspergillosis after allogeneic hematopoietic stem cell transplantation: new perspectives for patient management? Clin. Infect. Dis. 50:1598-1600.
348. Vissiennon, T. 1999. Fungal flora in chicken stalls and its etiopathogenic importance for humans and animals. Berl. Munch. Tierarztl. Wochenschr. 112:104-107.
349. Vítovec, J., P. Vladík, C. Proks, and P. Fragner. 1975. Mucormycosis (Mu-cor pusillus) with asteroids in a young bull. Acta Vet. Acad. Sci. Hung. 25:31-35.
350. Voigt, K., E. Cigelnik, and K. O'Donnell. 1999. Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal DNA sequence data. J. Clin. Microbiol. 37:3957-3964.
351. Voigt, K., and J. Wostemeyer. 2001. Phylogeny and origin of 82 Zygomy-cetes from all 54 genera of the Mucorales and Mortierellales based on combined analysis of actin and translation elongation factor EF-1alpha genes. Gene 270:113-120.
352. Vonberg, R. P., and P. Gastmeier. 2006. Nosocomial aspergillosis in outbreak settings. J. Hosp. Infect. 63:246-254.
353. Walsh, T. J., and D. P. Kontoyiannis. 2008. Editorial commentary: what is the role of combination therapy in management of zygomycosis? Clin. Infect. Dis. 47:372-374.
354. Wang, J., C. M. Harvey, J. H. Calhoun, L. Y. Yin, and J. T. Mader. 2002. Systemic Apophysomyces elegans after trauma: case report and literature review. Surg. Infect. (Larchmt) 3:283-289.
355. Warris, A., et al. 2001. Recovery of filamentous fungi from water in a paediatric bone marrow transplantation unit. J. Hosp. Infect. 47:143-148.
356. Weber, D. J., A. Peppercorn, M. B. Miller, E. Sickbert-Benett, and W. A. Rutala. 2009. Preventing healthcare-associated Aspergillus infections: review of recent CDC/HICPAC recommendations. Med. Mycol. 47(Suppl.): S199-S209.
357. Weinberg, W. G., B. H. Wade, G. Cierny III, D. Stacy, and M. G. Rinaldi. 1993. Invasive infection due to Apophysomyces elegans in immunocompe-tent hosts. Clin. Infect. Dis. 17:881-884.
358. Weitzman, I., and M. Y. Crist. 1979. Studies with clinical isolates of Cun-ninghamella. I. Mating behavior. Mycologia 71:1024-1033.
359. Weitzman, I., S. Whittier, J. C. McKitrick, and P. Della-Latta. 1995. Zygospores: the last word in identification of rare or atypical Zygomycetes isolated from clinical specimens. J. Clin. Microbiol. 33:781-783.
360. White, M. M., et al. 2006. Phylogeny of the Zygomycota based on nuclear ribosomal sequence data. Mycologia 98:872-884.
361. Wickline, C. L., T. G. Cornitius, and T. Butler. 1989. Cellulitis caused by Rhizomucor pusillus in a diabetic patient receiving continuous insulin infusion pump therapy. South. Med. J. 82:1432-1434.
362. Wieden, M. A., K. K. Steinbronn, A. A. Padhye, L. Ajello, and F. W. Chandler. 1985. Zygomycosis caused by Apophysomyces elegans. J. Clin. Microbiol. 22:522-526.
363. Wilson, A. P., S. Wright, and G. Bellingan. 2000. Disseminated fungal infection following falciparum malaria. J. Infect. 40:202-204.
364. Wilson, M., J. Robson, C. M. Pyke, and J. G. McCormack. 1998. Saksenaea vasiformis breast abscess related to gardening injury. Aust. N. Z. J. Med. 28:845-846.
365. Wilson, P. A. 2008. Zygomycosis due to Saksenaea vasiformis caused by a magpie peck. Med. J. Aust. 189:521-522.
366. Winn, R. E., P. D. Ramsey, and E. D. J. Adams. 1982. Traumatic mucor-mycosis secondary to Apophysomyces elegans, a new genus of the Mucorales. Clin. Res. 30:382A.
367. Woo, P. C., et al. 2010. Internal transcribed spacer region sequence heterogeneity in Rhizopus microsporus: implications for molecular diagnosis in clinical microbiology laboratories. J. Clin. Microbiol. 48:208-214.
368. Yagi, S., et al. 2008. Pulmonary mucormycosis (Cunninghamella bertholle-tiae) with cavitation diagnosed using ultra-thin fibre-optic bronchoscopy. Respirology 13:312-314.
369. Zeilender, S., D. Drenning, F. L. Glauser, and D. Bechard. 1990. Fatal Cunninghamella bertholletiae infection in an immunocompetent patient. Chest 97:1482-1483.
370. Zhang, R., J. W. Zhang, and H. M. Szerlip. 2002. Endocarditis and hem-orrhagic stroke caused by Cunninghamella bertholletiae infection after kidney transplantation. Am. J. Kidney Dis. 40:842-846.
371. Zhao, Y., et al. 2009. Primary cutaneous mucormycosis caused by Rhizomu-cor variabilis in an immunocompetent patient. Mycopathologia 168:243-247.
372. Zheng, R.-Y., and H. Jiang. 1995. Rhizomucor endophyticus sp. nov., an endophytic Zygomycetes from higher plants. Mycotaxon 56:455-466.
373. Zheng, R.-Y., and G.-Q. Chen. 1993. Another non-thermophilic Rhizomucor causing human primary cutaneous mucormycosis. Mycosystema 6:1-11.
374. Zheng, R.-Y., and G.-Q. Chen. 1991. A non-thermophilic Rhizomucor causing human primary cutaneous mucormycosis. Mycosystema 4:45-57.